FDA approved AstraZeneca's Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma.

Approval of Imfinzi marks the first and only perioperative immunotherapy indicated for muscle-invasive bladder cancer.

Imfinzi in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy ...

Avoidable mortality increased by an average of 33 deaths per 100,000 people across the United States from 2009 to 2019.

Everyone's favorite dwarf planet, Pluto, was discovered just 95 years ago. Here's the story of how the once-ninth planet was ...

(HealthDay News) — Avoidable mortality is increasing in the United States and decreasing in comparator countries, according to a study published online March 24 in JAMA Internal Medicine.

This approval of durvalumab marks the first and only perioperative immunotherapy regimen available in muscle-invasive bladder ...

HealthDay News — Avoidable mortality is increasing in the US and decreasing in comparator countries, according to a study published online March 24 in JAMA Internal Medicine.

These results suggest that the rise in avoidable mortality is driven by widespread factors across the entire US.

In baseball, it’s three strikes and you’re out — but in ERISA litigation, you apparently can get a fourth chance.

The following is a summary of “Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung ...

The EU directive on pay transparency raises many concerns, primarily because its implementation may complicate Polish laws, which so far have ...